Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_2
5
71%
Ph phase_3
2
29%

Phase Distribution

0

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
5(71.4%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 25 (71.4%)
Phase 32 (28.6%)

Trials by Status

not_yet_recruiting114%
active_not_recruiting114%
completed343%
enrolling_by_invitation114%
recruiting114%

Recent Activity

2 active trials
Showing 5 of 7
recruitingphase_3

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

NCT06948214
completedphase_2

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

NCT05250063
completedphase_2

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

NCT05364684
not_yet_recruitingphase_3

Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

NCT07129759
completedphase_2

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

NCT04614337
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06948214Phase 3

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Recruiting
NCT05250063Phase 2

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

Completed
NCT05364684Phase 2

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Completed
NCT07129759Phase 3

Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

Not Yet Recruiting
NCT04614337Phase 2

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

Completed
NCT05796440Phase 2

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

Enrolling By Invitation
NCT04806854Phase 2

PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)

Active Not Recruiting

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7